{
    "eid": "2-s2.0-85140808290",
    "title": "The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Affective disorders",
        "Inflammation",
        "Neuro-immune",
        "Neurotoxicity",
        "Oxidative and nitrosative stress",
        "Psychiatry"
    ],
    "authors": [
        "Abbas F. Almulla",
        "Yanin Thipakorn",
        "Asara Vasupanrajit",
        "Ali Abbas Abo Algon",
        "Chavit Tunvirachaisakul",
        "Ashwan Abdulzahra Hashim Aljanabi",
        "Gregory Oxenkrug",
        "Hussein K. Al-Hakeim",
        "Michael Maes"
    ],
    "citedby-count": 9,
    "ref-count": 198,
    "ref-list": [
        "The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites",
        "Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression",
        "The tryptophan catabolite or kynurenine pathway's role in major depression",
        "The tryptophan catabolite or kynurenine pathway in Alzheimer's disease: a systematic review and meta-analysis",
        "The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis",
        "The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments",
        "Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss",
        "Peripheral immune aberrations in fibromyalgia: a systematic review, meta-analysis and meta-regression",
        "Role of Kynurenine pathway and its metabolites in mood disorders: a systematic review and meta-analysis of clinical studies",
        "Tryptophan metabolism in alcoholism",
        "Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity",
        "The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites",
        "A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality",
        "Reactivity and degradation products of tryptophan in solution and proteins",
        "Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder",
        "Major depression induced by interferon-alpha in patients affected by hepatitis C virus",
        "Increased depressive ratings in patients with hepatitis C receiving interferon-\u03b1\u2013based immunotherapy are related to interferon-\u03b1\u2013induced changes in the serotonergic system",
        "Substrate oxidation by indoleamine 2,3-dioxygenase: evidence for a common reaction mechanism",
        "The role of the kynurenine pathway in suicidality in adolescent major depressive disorder",
        "An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation",
        "Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?",
        "Serum kynurenines correlate with depressive symptoms and disability in poststroke patients: a cross-sectional study",
        "Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression and the effects on Quinolinic Acid",
        "Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder",
        "A multivariate analysis of red blood cell membrane transports and plasma levels of L-tyrosine and L-tryptophan in depressed patients before treatment and after clinical improvement",
        "A study of tryptophan, kynurenine and serotonin transporter in first-episode drug-na\u00efve major depressive disorder",
        "Sleep disturbance and kynurenine metabolism in depression",
        "Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals",
        "Statistical Power Analysis for the Behavioral Sciences Routledge",
        "Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: a case-control study",
        "The biochemistry of affective disorders",
        "Tryptophan concentration in the cerebrospinal fluid of depressive patients",
        "Total and free tryptophan concentration in the plasma of depressive patients",
        "Decreased plasma tryptophan levels in major depression",
        "Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls",
        "Relationships between plasma, CSF and brain tryptophan",
        "Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression",
        "Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers",
        "Effects of contamination of blood specimens with liquid potassium-EDTA anticoagulant",
        "Plasma tryptophan and five other amino acids in depressed and normal subjects",
        "A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls",
        "Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes",
        "A nonparametric \u201ctrim and fill\u201d method of accounting for publication bias in meta-analysis",
        "Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis",
        "Elevated plasma homocysteine in association with decreased vitamin B(12), folate, serotonin, lipids and lipoproteins in depressed patients",
        "Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis",
        "Connecting inflammation with glutamate agonism in suicidality",
        "Correlation between brain tryptophan and plasma neutral amino acid levels following food consumption in rats",
        "The possible role of the kynurenine pathway in adolescent depression with melancholic features",
        "Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis",
        "CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls",
        "Radical scavenging properties of tryptophan metabolites. Estimation of their radical reactivity",
        "Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms",
        "Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms",
        "Monoamine-related markers of depression: changes following treatment",
        "Tryptophan catabolites in bipolar disorder: a meta-analysis",
        "Role of the kynurenine pathway and the endocannabinoid system as modulators of inflammation and personality traits",
        "Exercise affects symptom severity but not biological measures in depression and somatization \u2013 results on IL-6, neopterin, tryptophan, kynurenine and 5-HIAA",
        "Cochrane Handbook for Systematic Reviews of Interventions",
        "Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression",
        "Bipolar mania and plasma amino acids: increased levels of glycine",
        "A simple HPLC-MS/MS method for determination of tryptophan, kynurenine and kynurenic acid in human serum and its potential for monitoring antidepressant therapy",
        "Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer",
        "Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation",
        "Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression",
        "Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome",
        "High kynurenine (a tryptophan metabolite) predicts remission in patients with major depression to add-on treatment with celecoxib",
        "Values of cytokines and tryptophan metabolites over a 12 Weeks time course in patients with depression and somatoform disorder",
        "Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs",
        "Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-na\u00efve patients with major depressive disorder: an exploratory pilot case-control study",
        "Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect",
        "Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms",
        "A meta-analysis of oxidative stress markers in depression",
        "The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder",
        "Plasma tryptophan levels and plasma tryptophan/neutral amino acids ratio in patients with mood disorder, patients with obsessive-compulsive disorder, and normal subjects",
        "Predictive value of tryptophan/large neutral amino acids ratio to antidepressant response",
        "A review on the acute phase response in major depression",
        "A review on citation amnesia in depression and inflammation research",
        "Precision nomothetic medicine in depression research: a new depression model, and new endophenotype classes and pathway phenotypes, and A digital self",
        "The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder",
        "The serotonin hypothesis of major depression: a review",
        "Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway",
        "False dogmas in mood disorders research: towards a nomothetic network approach",
        "Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients",
        "The relationships between the availability ofL-tryptophan to the brain, the spontaneous HPA-axis activity, and the HPA-axis responses to dexamethasone in depressed patients",
        "Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression",
        "Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression",
        "Increased plasma serine concentrations in depression",
        "Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism",
        "Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers",
        "Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response",
        "Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation",
        "Treatment with interferon-alpha (IFN\u03b1) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN\u03b1-induced depressive and anxiety symptoms and immune activation",
        "The immune effects of TRYCATs (tryptophan catabolites along the Ido pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation",
        "The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression",
        "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness",
        "Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity",
        "Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity",
        "The new \u20185-HT\u2019 hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "Development of a novel staging model for affective disorders using partial least squares bootstrapping: effects of lipid-associated antioxidant defenses and neuro-oxidative stress",
        "Development of a novel staging model for affective disorders using partial least squares bootstrapping: effects of lipid-associated antioxidant defenses and neuro-oxidative stress",
        "Upregulation of the nitrosylome in bipolar disorder type 1 (BP1) and major depression, but not BP2: increased IgM antibodies to nitrosylated conjugates are associated with indicants of leaky gut",
        "Adverse childhood experiences predict the phenome of affective disorders and these effects are mediated by staging",
        "The Immune Profile of Major Dysmood Disorder: Proof of Concept and Mechanism Using the Precision Nomothetic Psychiatry Approach",
        "Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression",
        "The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies",
        "Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment",
        "Predictive value of amino acids in the treatment of major depression with fluvoxamine",
        "The specific binding of L-tryptophan to serum albumin",
        "Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder",
        "Free tryptophan response to intravenous insulin in depressed patients",
        "The association between plasma tryptophan catabolites and depression: the role of symptom profiles and inflammation",
        "Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder",
        "Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects",
        "Plasma amino acid profiles in relation to clinical response to moclobemide in patients with major depression. Danish University Antidepressant Group",
        "Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan",
        "Tryptophan tolerance and metabolism in endogenous depression",
        "Tryptophan depletion and depressive vulnerability",
        "Increase in nitric oxide levels and mitochondrial membrane potential in platelets of untreated patients with major depression",
        "The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders",
        "Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder",
        "Effects of adjunctive inflammatory modulation on IL-1\u03b2 in treatment resistant bipolar depression",
        "Tryptophan breakdown pathway in bipolar mania",
        "Kynurenine pathway in major depression: evidence of impaired neuroprotection",
        "Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form",
        "Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression",
        "Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis",
        "Plasma amino acid profile in major depressive disorder: analyses in two independent case-control sample sets",
        "Kynurenine pathway in depression: a systematic review and meta-analysis",
        "Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder",
        "Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls",
        "Serotonin-kynurenine hypothesis of depression: historical overview and recent developments",
        "The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder",
        "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews",
        "Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study",
        "Tryptophan transport through the blood-brain barrier: in vivo measurement of free and albumin-bound amino acid",
        "EDTA in vacutainer tubes can interfere with plasma amino acid analysis",
        "Peripheral and central kynurenine pathway abnormalities in major depression",
        "Tryptophan: antioxidant or target of oxidative stress? A quantum chemistry elucidation",
        "Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes",
        "Low plasma levels of l-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients",
        "Tryptophan breakdown and cognition in bipolar disorder",
        "Kynurenine pathway and white matter microstructure in bipolar disorder",
        "Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder",
        "Tryptophan and kynurenine metabolites: are they related to depression?",
        "Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients",
        "Serotonin Function and Depression: Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in Depressed Patients and Healthy Comparison Subjects",
        "Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?",
        "Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations",
        "Neuroplasticity and depression: rewiring the brain's networks through pharmacological therapy (Review)",
        "Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report",
        "Melatonin and tryptophan derivatives as free radical scavengers and antioxidants",
        "Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases",
        "Psychobiological aspects of somatoform disorders: contributions of monoaminergic transmitter systems",
        "The effects of tryptophan depletion on neural responses to emotional words in remitted depression",
        "Plasma tryptophan to large neutral amino acid ratios in depressed and normal subjects",
        "Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy",
        "Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder",
        "Quinolinic acid induces oxidative stress in rat brain synaptosomes",
        "Possible role of nitric oxide and adrenomedullin in bipolar affective disorder",
        "Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder",
        "Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder",
        "Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder",
        "Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder",
        "Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients",
        "Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls",
        "Tryptophan, affective disorder and stress. An hypothesis",
        "5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones",
        "Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: a meta-analysis of mean differences and variability",
        "The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression",
        "The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls",
        "A comparison of serum and plasma blood collection tubes for the integration of epidemiological and metabolomics data",
        "Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders",
        "Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?",
        "Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder",
        "The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine",
        "Nitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorder",
        "(13)C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder",
        "Central levels of tryptophan metabolites in subjects with bipolar disorder",
        "Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder",
        "A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder",
        "Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: a systematic review and meta-analysis",
        "Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis",
        "Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression",
        "Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range",
        "Ido and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity",
        "The effect of antidepressant drugs on plasma kynurenine in depressed patients",
        "Kynurenine pathway changes in late-life depression with memory deficit",
        "Kynurenine pathway changes in late-life depression",
        "Serum kynurenic acid is reduced in affective psychosis",
        "Potential clinical utility of plasma amino acid profiling in the detection of major depressive disorder",
        "The tryptophan pathway targeting antioxidant capacity in the placenta",
        "Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder",
        "Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression",
        "Effect of albumin binding and amino acid competition on tryptophan uptake into brain",
        "Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression",
        "Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder"
    ],
    "affiliation": [
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Najaf",
            "@id": "60109789",
            "affilname": "The Islamic University, Najaf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109789",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60015849",
            "affilname": "Tufts University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015849",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Najaf",
            "@id": "128330848",
            "affilname": "Iraqi Education Ministry",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128330848",
            "affiliation-country": "Iraq"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}